Dimerix - Public Comps and Valuation Multiples

Dimerix Overview

About Dimerix

Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD, as well as the proprietary ReceptorHIT assay technology. It pursues new product concepts and applies deep scientific knowledge to the discovery of products from early-stage development through to commercialisation. Dimerix products will target multiple territories. The Group has only operated in one Segment, being investment in research and development of biopharmaceutical drugs.

Founded

1975

HQ

Employees

Website

dimerix.com

Sectors

Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $6.9M

LTM EBITDA -$12.5M

EV

$143M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Dimerix Financials

As of October 2025, Dimerix reported last 12-month revenue of $6.9M and EBITDA of -$12.5M.

In the same period, Dimerix achieved -$5.3M in LTM net income.

See Dimerix valuation multiples based on analyst estimates

Dimerix P&L

In the most recent fiscal year, Dimerix reported revenue of $3.6M and EBITDA of -$20.7M.

Dimerix expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Dimerix valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$6.9M	XXX	$3.6M	XXX	XXX	XXX
Gross Profit	n/a	XXX	$3.6M	XXX	XXX	XXX
Gross Margin	n/a	XXX	100%	XXX	XXX	XXX
EBITDA	-$12.5M	XXX	-$20.7M	XXX	XXX	XXX
EBITDA Margin	-182%	XXX	-571%	XXX	XXX	XXX
EBIT	-$12.7M	XXX	-$20.8M	XXX	XXX	XXX
EBIT Margin	-185%	XXX	-573%	XXX	XXX	XXX
Net Profit	-$5.3M	XXX	-$8.6M	XXX	XXX	XXX
Net Margin	-77%	XXX	-237%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Dimerix including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $6.9M. EBITDA for the last twelve months was -$12.5M. In the most recent fiscal year, Dimerix achieved $3.6M in revenue and -$20.7M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$6.9M	Analyst estimates available to subscribers	$3.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$3.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	100.0% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	-$12.5M	Analyst estimates available to subscribers	-$20.7M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	-181.8% EBITDA margin	Analyst estimates available to subscribers	-570.7% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$12.7M	Analyst estimates available to subscribers	-$20.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-184.6% EBIT margin	Analyst estimates available to subscribers	-572.9% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$5.3M	Analyst estimates available to subscribers	-$8.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-77.2% net profit margin	Analyst estimates available to subscribers	-237.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Dimerix

This financial data table provides comprehensive performance metrics for Dimerix, a company based in Australia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Dimerix generated $6.9M in revenue over the last twelve months.
The company achieved -$12.5M in EBITDA over the last twelve months.
Net income over the last twelve months reached -$5.3M.

Fiscal Year Performance

In the most recent fiscal year, Dimerix reported $3.6M in total revenue.
Fiscal year EBITDA was -$20.7M.
The company maintained a gross profit margin of 100.0% in the most recent fiscal year.
EBITDA margin for the fiscal year was -570.7%.
Net profit margin reached -237.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Dimerix. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Dimerix Stock Performance

Dimerix has current market cap of AUD 288M (or $187M), and EV of AUD 220M (or $143M).

Market Cap Evolution

Dimerix Stock Data

As of November 14, 2025, Dimerix's stock price is AUD 0 (or $0).

See Dimerix trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$143M	$187M	XXX	XXX	XXX	XXX	$-0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Dimerix Valuation Multiples

Dimerix's trades at 73.4x EV/Revenue multiple, and -7.7x EV/EBITDA.

See valuation multiples for Dimerix and 15K+ public comps

Dimerix Financial Valuation Multiples

As of November 14, 2025, Dimerix has market cap of $187M and EV of $143M.

Equity research analysts estimate Dimerix's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Dimerix has a P/E ratio of -35.1x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$187M	XXX	$187M	XXX	XXX	XXX
EV (current)	$143M	XXX	$143M	XXX	XXX	XXX
EV/Revenue	20.7x	XXX	73.4x	XXX	XXX	XXX
EV/EBITDA	-11.4x	XXX	-7.7x	XXX	XXX	XXX
EV/EBIT	-11.2x	XXX	-7.7x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	-35.1x	XXX	-19.0x	XXX	XXX	XXX
EV/FCF	5.1x	XXX	13.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Dimerix Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Dimerix Margins & Growth Rates

Dimerix's last 12 month revenue growth is 253%

Dimerix's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $1.7M for the same period.

Dimerix's rule of 40 is -699% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Dimerix's rule of X is 450% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Dimerix and other 15K+ public comps

Dimerix Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	253%	XXX	281%	XXX	XXX	XXX
EBITDA Margin	-182%	XXX	-952%	XXX	XXX	XXX
EBITDA Growth	-214%	XXX	n/a	XXX	XXX	XXX
Rule of 40	-699%	XXX	-699%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	450%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$1.7M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	489%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	673%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial